GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks

19th September 2019 Uncategorised 0

With the federal spotlight on e-cigarette use, the FDA has grown increasingly wary of nicotine-based products with risks of abuse. That didn’t stop GlaxoSmithKline from winning a recommendation for its over-the-counter nicotine spray.

More: GSK's oral nicotine spray wins divided FDA panel's backing despite abuse risks
Source: fierce